Document Classification

Section Type: RESULTS

Text: Hemoglobin and hematocrit experienced similar increases in both groups : from 8. 5 + / - 0. 9 g/dL and 25. 8 + / - 2. 7 % to 11. 7 + / - 0. 6 g/dL and 34. 7 + / - 1. 6 % (P < 0. 001) in patients receiving rHuEPO, and from 8. 9 + / - 0. 8 and 27 + / - 2. 2 % to 11. 8 + / - 0. 4 g/dL and 35. 1 + / - 1. 5 % (P < 0. 001) in subjects treated with ND.